Quarterly report [Sections 13 or 15(d)]

Stockholders’ Deficit (Tables)

v3.26.1
Stockholders’ Deficit (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Redeemable Common Stock

The activity of the redeemable common stock is as follows:

 

Value upon share issuance on December 15, 2025   $ 1,228  
Less: decrease in value through March 31, 2026     (328 )
Plus: increase in value through May 26, 2026     63  
Redeemable stock reclassified to permanent equity on May 26, 2026   $ 963  
Schedule of Assets Acquired and Liabilities Assumed

The following are the fair values of major classes of assets acquired and liabilities assumed as of the May 26, 2026 acquisition date (in thousands of dollars):

 

       
Assets acquired:        
Receivable from DNA Holdings     109  
Intangible assets-software     1,100  
Intangible assets-trademarks     185  
Total asset     1,394  
         
Liabilities assumed:        
Accounts payable     104  
         
Net assets acquired   $ 1,290  
         
Derecognition of equity investment   $ 1,290